Nov 09, 2021 / 01:50PM GMT
Judah C. Frommer - Crédit Suisse AG - Research Division - Senior Analyst
Hi, and welcome to the 2021 Credit Suisse Healthcare Conference. I'm Judah Frommer, the senior analyst covering biotech at CS. I'm happy to introduce ICON and Brendan Brennan, who will be presenting in the next couple of minutes. (Operator Instructions) And with that, I'll turn it over to ICON. Thanks again.
Brendan Brennan - ICON Public Limited Company - CFO
Thank you, Judah. It's great to be asked if only virtually the Credit Suisse conference. Those of you who know ICON well will know that I'm usually based in Dublin, and you may be somewhat confused by the sun streaming through the window here today because I'm actually in our Raleigh office in North Carolina. So enjoying some nice U.S. sunshine and very excited about the fact that later in the week, we'll be meeting some investors face-to-face for the first time in what feels like quite some time.
I'm ably accompanied today by Kate Haven, who is our new VP of Investor Relations. Kate's doing the
ICON PLC at Credit Suisse Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
